BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 24565289)

  • 1. APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.
    Hendrie HC; Murrell J; Baiyewu O; Lane KA; Purnell C; Ogunniyi A; Unverzagt FW; Hall K; Callahan CM; Saykin AJ; Gureje O; Hake A; Foroud T; Gao S
    Int Psychogeriatr; 2014 Jun; 26(6):977-85. PubMed ID: 24565289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.
    Hall K; Murrell J; Ogunniyi A; Deeg M; Baiyewu O; Gao S; Gureje O; Dickens J; Evans R; Smith-Gamble V; Unverzagt FW; Shen J; Hendrie H
    Neurology; 2006 Jan; 66(2):223-7. PubMed ID: 16434658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is ApoE epsilon4 associated with cognitive functioning in African Americans diagnosed with Alzheimer Disease? An exploratory study.
    Mount DL; Ashley AV; Lah JJ; Levey AI; Goldstein FC
    South Med J; 2009 Sep; 102(9):890-3. PubMed ID: 19668025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
    Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
    PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana.
    Hendrie HC; Ogunniyi A; Hall KS; Baiyewu O; Unverzagt FW; Gureje O; Gao S; Evans RM; Ogunseyinde AO; Adeyinka AO; Musick B; Hui SL
    JAMA; 2001 Feb; 285(6):739-47. PubMed ID: 11176911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.
    Lim AS; Yu L; Kowgier M; Schneider JA; Buchman AS; Bennett DA
    JAMA Neurol; 2013 Dec; 70(12):1544-51. PubMed ID: 24145819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental factors influencing the link between APOE ε4 and Alzheimer's disease (AD) risk.
    Fluegge K
    Int Psychogeriatr; 2019 Feb; 31(2):305-306. PubMed ID: 29991368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults.
    Rajan KB; Mcaninch EA; Wilson RS; Dhana A; Evans-Lacko S; Evans DA
    Neurology; 2024 Apr; 102(7):e209168. PubMed ID: 38447103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.
    Ma F; Wang J; Miao R; Zhao W; Wang Q
    Neuropsychobiology; 2011; 64(2):102-9. PubMed ID: 21701228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.
    Tang MX; Stern Y; Marder K; Bell K; Gurland B; Lantigua R; Andrews H; Feng L; Tycko B; Mayeux R
    JAMA; 1998 Mar; 279(10):751-5. PubMed ID: 9508150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the role of Amerindian genetic ancestry and the ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population.
    Marca-Ysabel MV; Rajabli F; Cornejo-Olivas M; Whitehead PG; Hofmann NK; Illanes Manrique MZ; Veliz Otani DM; Milla Neyra AK; Castro Suarez S; Meza Vega M; Adams LD; Mena PR; Rosario I; Cuccaro ML; Vance JM; Beecham GW; Custodio N; Montesinos R; Mazzetti Soler PE; Pericak-Vance MA
    Neurobiol Aging; 2021 May; 101():298.e11-298.e15. PubMed ID: 33541779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.
    Boyle PA; Buchman AS; Wilson RS; Kelly JF; Bennett DA
    Neuroepidemiology; 2010; 34(1):43-9. PubMed ID: 19907191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease, genes, and environment: the value of international studies.
    Hendrie HC; Hall KS; Ogunniyi A; Gao S
    Can J Psychiatry; 2004 Feb; 49(2):92-9. PubMed ID: 15065742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.
    Beydoun MA; Beydoun HA; Kaufman JS; An Y; Resnick SM; O'Brien R; Ferrucci L; Zonderman AB
    J Am Geriatr Soc; 2013 Apr; 61(4):525-34. PubMed ID: 23581910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline.
    Rajan KB; Wilson RS; Skarupski KA; Mendes de Leon CF; Evans DA
    Psychosom Med; 2014 Feb; 76(2):101-8. PubMed ID: 24434953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
    Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International studies in dementia with particular emphasis on populations of African origin.
    Hendrie HC; Murrell J; Gao S; Unverzagt FW; Ogunniyi A; Hall KS
    Alzheimer Dis Assoc Disord; 2006; 20(3 Suppl 2):S42-6. PubMed ID: 16917194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.
    Hayden KM; Zandi PP; West NA; Tschanz JT; Norton MC; Corcoran C; Breitner JC; Welsh-Bohmer KA;
    Arch Neurol; 2009 Nov; 66(11):1378-83. PubMed ID: 19901170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.